Partner
Michael Dixon, C.P.A
Principal, Sanderling Ventures
- Firm
- Sanderling Ventures
- Title
- Principal
- Role
- Principal
- Known as
- Investor
Record updated 21 September 2026
About
Michael Dixon, CPA CA has over 18 years of experience working in an executive role for venture-backed companies. As CEO of Therillia Development Company Inc., Mr. Dixon oversees the development of therapeutic assets of interest to Therillia’s shareholders, including dalcetrapib. Prior to his role in Therillia, Mr. Dixon was Chief Financial Officer of Gemin X Pharmaceuticals. At
Is this you? Remove my profile